Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

EM TopicsRespiratory failure (type 1 & 2)

EM · Respiratory failure (type 1 & 2)

Respiratory failure (type 1 and type 2)

Also known as Type 1 respiratory failure · Type 2 respiratory failure · Hypoxaemic respiratory failure · Hypercapnic respiratory failure

Respiratory failure — the type 1 (hypoxaemic) and type 2 (hypercapnic) classification from the arterial blood gas, the oxygen targets (94 to 98 per cent for most, 88 to 92 per cent for the CO2 retainer), the oxygen device ladder with inspired fractions, the mechanism by which excess oxygen worsens the CO2 (the Haldane effect and the loss of hypoxic pulmonary vasoconstriction), and the escalation to non-invasive ventilation (BiPAP for type 2, CPAP for type 1 pulmonary oedema) and invasive ventilation. ACEM-primary, globally tagged.

high10 referencesUpdated 26 July 202616 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

ACEMFRCEMABEMFRCPCCCFPEMEBEEM

Red flags

  • A rising PaCO2 in a previously type-1 patient signals fatigue and impending respiratory arrest — escalate to ventilatory support without delay
  • A CO2 retainer given uncontrolled high-flow oxygen may develop CO2 narcosis — target 88 to 92 per cent, not 94 to 98 per cent
  • A patient who is becoming drowsy, slowing their respiratory rate, or losing the accessory-muscle effort is tiring — prepare for ventilation
  • A normal chest radiograph does not exclude respiratory failure — the ABG is the defining test
  • Naloxone 400 micrograms intravenously reverses the opioid-induced type 2 respiratory failure — titrate to avoid the acute withdrawal
On this page

Related topics

  • Community-acquired pneumonia
  • Acute exacerbation of chronic obstructive pulmonary disease
  • Acute severe asthma
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

ACEMFRCEMABEMFRCPCCCFPEMEBEEM

Red flags

  • A rising PaCO2 in a previously type-1 patient signals fatigue and impending respiratory arrest — escalate to ventilatory support without delay
  • A CO2 retainer given uncontrolled high-flow oxygen may develop CO2 narcosis — target 88 to 92 per cent, not 94 to 98 per cent
  • A patient who is becoming drowsy, slowing their respiratory rate, or losing the accessory-muscle effort is tiring — prepare for ventilation
  • A normal chest radiograph does not exclude respiratory failure — the ABG is the defining test
  • Naloxone 400 micrograms intravenously reverses the opioid-induced type 2 respiratory failure — titrate to avoid the acute withdrawal
The one-line answer

Respiratory failure is read off the arterial blood gas, and the ABG does three jobs at once. It splits type 1 (hypoxaemic — PaO₂ under 8 kPa, or 60 mmHg, with a normal or low PaCO₂) from type 2 (hypercapnic — PaCO₂ over 6.5 kPa, or 50 mmHg). It sets the oxygen target — 94–98 per cent for most patients, 88–92 per cent for the CO₂ retainer. And it times the ventilatory escalation — BiPAP for the acidotic COPD type 2, CPAP for cardiogenic oedema, invasive ventilation when the patient tires. Get the type wrong and you give the wrong oxygen; miss the fatigue and the patient arrests.[1]

Meet the patient

A 68-year-old with known COPD is brought in drowsy and slow. The ambulance crew gave him high-flow oxygen on scene for low saturations — the right call for almost anyone else, the wrong call for him. His gas: pH 7.28, PaCO₂ 8.2 kPa, PaO₂ 7.6 kPa, bicarbonate 32. That is acute-on-chronic type 2 respiratory failure, and the high-flow oxygen has pushed his CO₂ higher still.[1]

The two questions that decide his next hour are the two that decide every respiratory failure: what type is it? (the ABG answers in three minutes) and what oxygen target does that type demand? For him, 88–92 per cent — never 94–98. The Austin trial showed high-flow oxygen raises mortality in prehospital COPD, so your first move is to take it off and reach for the Venturi mask.[9]

Emergency Medicine Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Emergency Medicine fellowship library.

Sign in to continueSee pricing
References10ShowHide
  1. [1]O'Driscoll BR, Howard LS, Earis J, et al. BTS guideline for oxygen use in adults in healthcare and emergency settings Thorax, 2017.PMID 28507176
  2. [2]Matthay MA, Arabi Y, Arroliga AC, et al. A New Global Definition of Acute Respiratory Distress Syndrome Am J Respir Crit Care Med, 2024.PMID 37487152
  3. [3]Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med, 2000.PMID 10793162
  4. [4]Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome N Engl J Med, 2013.PMID 23688302
  5. [5]Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries JAMA, 2016.PMID 26903337
  6. [6]Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease N Engl J Med, 1995.PMID 7651472
  7. [7]Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial Lancet, 2000.PMID 10859037
  8. [8]Ram FSF, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease Cochrane Database Syst Rev, 2004.PMID 15266518
  9. [9]Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial BMJ, 2010.PMID 20959284
  10. [10]Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure N Engl J Med, 2015.PMID 25981908

Test yourself

Practise what you just read

  • 8 MCQs
Emergency Medicine Pro

$29/ monthor $279 / year

The complete Emergency Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousResearch, evidence-based medicine and biostatistics — appraising and applying evidence at the bedsideResearch, EBM and biostatisticsNextResuscitation team leadership and crisis resource managementResuscitation team leadership & CRM

Related topics

  • Community-acquired pneumonia
  • Acute exacerbation of chronic obstructive pulmonary disease
  • Acute severe asthma